Search…

Lates News

20/09/2025

The U.S. Food and Drug Administration announced on Friday that it has approved a new subcutaneous injection formulation of Merck's blockbuster cancer therapy Keytruda, providing a more convenient way of administration for this widely used cancer immunotherapy.

Latest

4 m ago

Goldman Sachs' Chief U.S. Equity Strategist David Kostin: Raised the S&P 500 index target for the next three months by 2% to 6,800 points. Raised the target for the next six months to 7,000 points, and raised the target for the next 12 months to 7,200 points.

4 m ago

Goldman Sachs' Chief US Equity Strategist David Kostin: Raised the S&P 500 index target for the next three months by 2% to 6800 points. Raised the target for the next six months to 7000 points, and raised the target for the next 12 months to 7200 points.

13 m ago

Cryptocurrency custody company BitGo applies for its first initial public offering (IPO).

14 m ago

The MSCI Emerging Markets Stock Index fell by 0.4%, narrowing the cumulative increase for the week to slightly over 1.0%. The MSCI Emerging Markets Currency Index dropped by 0.2%, marking the worst single-day performance in the past three weeks. The Bloomberg Dollar Spot Index rose by 0.2%, supported by quick cash flows into the US dollar.

14 m ago

Mingsheng Company's developing country stock index dropped by 0.4%, narrowing the total weekly gain to just over 1.0%. The MSCI Emerging Markets Currency Index fell by 0.2%, marking its worst single-day performance in the past three weeks, but still showing a cumulative increase of 0.8% so far in September. The Bloomberg Spot Dollar Index rose by 0.2%, with the US dollar receiving support from the quick money.

See all latest